OLLOBOT to Make Its Debut at CES 2026
LAS VEGAS, Dec. 15, 2025 /PRNewswire/ -- OLLOBOT, a brand focused on fusing advanced technology with emotional companionship, will make its first appearance at CES 2026 (January 6–9). At Booth 53571 in Halls A-D of the Las Vegas Convention Center,...
Minghui Pharmaceutical Announces FDA clearance of IND to Initiate Global Phase Ⅲ Trials of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Thyroid Eye Disease
SHANGHAI and HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ -- Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announced the U.S. Food and Drug...
iCHASE Introduces the World's First AI-Powered Bird Deterrent With Full Data Tracking at IPPE 2026
ATLANTA, Dec. 15, 2025 /PRNewswire/ -- iCHASE, a global leader in AI-driven agricultural biosecurity solutions, will showcase the world's first AI-powered bird deterrent system with full data tracking capabilities at the 2026 International...
2025 Gaobai Relay 10th Anniversary Grand Final Held Along the Shanghai Riverside
SHANGHAI, Dec. 15, 2025 /PRNewswire/ -- The 10th Anniversary and 2025 Grand Final of the Gaobai Relay was held on December 7 along the Huangpu–Xuhui Riverside in Shanghai. The starting gun fired at 8:00 a.m., signaling the beginning of the intense...
Radisson Hotel Group signs three strategic hotels in the Philippines, introducing a dual brand at SM Mall of Asia and expanding in Santa Rosa
BRUSSELS, Dec. 15, 2025 /PRNewswire/ -- Radisson Hotel Group has signed three new properties in the Philippines, with SM Hotels and Conventions Corporation strengthening its presence in Metro Manila and Greater Manila and reinforcing the country's...
Ascletis Announces Positive Topline Results from U.S. Phase I Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor
- The elimination half-life of ASC50 after a single oral dose was 43, 89, 91, 87, 104, and 85 hours for 10 mg, 30 mg, 100 mg, 200 mg, 400 mg, and 600 mg, respectively, supporting once - daily or potentially once-weekly oral dosing. - ASC50 had...
MEDEZE Receives Frost & Sullivan's 2025 Southeast Asia Company of the Year Recognition for Leadership in Stem Cell Banking and Regenerative Medicine
The company is revolutionizing regenerative healthcare through innovation, clinical alignment, and GMP-grade excellence across Southeast Asia SAN ANTONIO, Dec. 15, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce that MEDEZE Group...
Who Are China's Top 100 Most International Privately-Owned Enterprises?
HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ -- China's top international privately-owned enterprises represent a distinct and increasingly influential group within the global economy – companies whose international presence is defined less by export...